Drug carriers endowed with photothermal effects will
allow the
drug delivery system to release drugs in a thermal-stimuli manner.
In addition, the photothermal therapy (PTT) will also interplay with
therapeutic drugs loaded in the carrier to exhibit synergistic bioactivity
for various disease treatment. However, endowing the drug carrier
with photothermal and synergistic therapeutic effects still has challenge.
Herein, we demonstrate that surface modification of porous silicon
(PSi) with polydopamine (PDA) could endow the classical drug carrier
with a significant photothermal effect for advanced antibacterial
therapy and wound disinfection. Specifically, the PSi surface interacts
with a Cu2+/PDA complex via a simple and fast surface reduction-induced
deposition method, forming the unique CuPDA coated PSi microcarrier
(CuPPSi) without blocking the mesoporous structure. The CuPPSi carrier
generates a higher near-infrared (NIR) photothermal efficiency and
improved drug loading capacity owing to the abundant functional groups
of PDA. Stimuli-responsive release of antibacterial Cu2+ and loaded curcumin (Cur) from CuPPSi can be realized under multiple
stimuli including pH, reactive oxygen species and NIR laser irradition.
Benefited from the carrier’s intrinsic multimodal therapy,
the CuPPSi-Cur platform exhibits amplified, broad-spectrum, and synergistic
antibacterial effect, killing more than 98% for both Staphylococcus aureus and Escherichia
coli at a mild PTT temperature (∼45 °C).
Notably, the combined therapy promotes migration of fibroblasts with
no significant cytotoxicity as revealed through cell experiments in vitro. In bacteria-infected mice model, efficient bacterial
ablation and wound healing are further demonstrated with negligible
side effects in vivo. Overall, the rational design
of a drug carrier with photothermal and therapeutic effects provides
a novel intervention for amplifing wound disinfection clinically.